Abstract
Reactive astrogliosis is a prominent feature of the brain inflammatory response and it represents a hallmark of many CNS pathologies including Alzheimer’s and Parkinson’s diseases and amyotrophic lateral sclerosis. While in physiological conditions astrocytes serve as multifunctional housekeeping cells, once activated they may affect neuronal survival in many different ways. Depending on the type of the stimuli and/or pathological conditions reactive astrogliosis may lead to either neuroprotective or neurotoxic inflammatory responses. Here we summarize the current knowledge of the origins and neuropathological features of reactive astrogliosis. Furthermore, we discuss the role and the potential of astrocytes as resident brain immune cells with particular emphasis on how astrocyte immune profiles may determine the cross talk between activated astrocytes and neurons in acute brain injuries such as stroke versus nonresolving, chronic inflammation associated with neurodegenerative disorders. Finally, because of the complex nature of the brain inflammatory response and its relevance in drug discovery programs, we highlight the value and importance of live imaging models in which different elements of neuroinflammation, including astrocytes activation and glia/neuron cross talk, can be visualized and studied in real time.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AD:
-
Alzheimer’s disease
- ALS:
-
Amyotrophic lateral sclerosis
- BBB:
-
Blood–brain barrier
- CCD:
-
Coupled charged device
- CNS:
-
Central nervous system
- ERE:
-
Estrogen responsive element
- Fluc:
-
Firefly luciferase
- FTD:
-
Fronto-temporal dementia
- GFAP:
-
Glial fibrillary acidic protein
- GFP:
-
Green fluorescent protein
- ICAM-1:
-
Intercellular adhesion molecule 1
- IFN-γ:
-
Interferon gamma
- IL-1β:
-
Interleukin-1beta
- IL-6:
-
Interleukin-6
- iNOS:
-
Inducible nitric oxide synthase
- MCAO:
-
Middle cerebral artery occlusion
- MHC:
-
Major histocompatibility complex
- NF-κB:
-
Nuclear factor kappa B
- NO:
-
Nitric oxide
- NPCs:
-
Neuronal progenitor cells
- PD:
-
Parkinson’s disease
- ROS:
-
Reactive oxygen species
- SOD1:
-
Cu/Zn Superoxide Dismutase 1
- TDP-43:
-
Tar binding protein 43
- TLRs:
-
Toll-like receptors
- TNF-α:
-
Tumor necrosis factor alpha
References
Abdel-Haq N, Hao HN, Lyman WD (1999) Cytokine regulation of CD40 expression in fetal human astrocyte cultures. J Neuroimmunol 101:7–14
Aloisi F, Ria F, Penna G, Adorini L (1998) Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol 160:4671–4680
Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA (2010) Glial and neuronal control of brain blood flow. Nature 468:232–243
Bae MK, Kim SR, Lee HJ, Wee HJ, Yoo MA, Ock Oh S, Baek SY, Kim BS, Kim JB, Sik-Yoon BSK (2006) Aspirin-induced blockade of NF-kappaB activity restrains up-regulation of glial fibrillary acidic protein in human astroglial cells. Biochim Biophys Acta 1763(3):282–289
Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312:1389–1392
Bsibsi M, Persoon-Deen C, Verwer RW, Meeuwsen S, Ravid R, Van Noort JM (2006) Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 53:688–695
Buffo A, Rite I, Tripathi P, Lepier A, Colak D, Horn AP et al (2008) Origin and progeny of reactive gliosis: a source of multipotent cells in the injured brain. Proc Natl Acad Sci U S A 105:3581–3586
Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN et al (1999) Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23:297–308
Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB et al (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A 90:10061–10065
Carson MJ, Thrash JC, Walter B (2006) The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin Neurosci Res 6:237–245
Choi HB, Gordon GR, Zhou N, Tai C, Rungta RL, Martinez J et al (2012) Metabolic communication between astrocytes and neurons via bicarbonate-responsive soluble adenylyl cyclase. Neuron 75:1094–1104
Cordeau P Jr, Lalancette-Hebert M, Weng YC, Kriz J (2008) Live imaging of neuroinflammation reveals sex and estrogen effects on astrocyte response to ischemic injury. Stroke 39:935–942
Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K (2007) Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 10:608–614
Eng LF, Ghirnikar RS, Lee YL (2000) Glial fibrillary acidic protein: Gfap-thirty-one years (1969–2000). Neurochem Res 25:1439–1451
Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV (2004) Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 24:2143–2155
Fawcett JW, Asher RA (1999) The glial scar and central nervous system repair. Brain Res Bull 49:377–391
Garcia-Segura LM, Chowen JA, Parducz A, Naftolin F (1994) Gonadal hormones as promoters of structural synaptic plasticity: cellular mechanisms. Prog Neurobiol 44:279–307
Gong YH, Parsadanian AS, Andreeva A, Snider WD, Elliott JL (2000) Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J Neurosci 20:660–665
Gordon GR, Choi HB, Rungta RL, Ellis-Davies GC, MacVicar BA (2008) Brain metabolism dictates the polarity of astrocyte control over arterioles. Nature 456:745–749
Gravel M, Weng YC, Kriz J (2011) Model system for live imaging of neuronal responses to injury and repair. Mol Imaging 10:434–445
Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A et al (2011) Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 29(9):824–828
Hall ED, Oostveen JA, Gurney ME (1998) Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23:249–256
Hamby ME, Sofroniew MV (2010) Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics 7:494–506
Heneka MT, Sastre M, Dumitrescu-Ozimek L, Dewachter I, Walter J, Klockgether T et al (2005) Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice. J Neuroinflammation 2:22
Herrmann M, Ehrenreich H (2003) Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Restor Neurol Neurosci 21:177–190
Hutter E, Boridy S, Labreque S, Lalancette-Hébert M, Kriz J, Winnik F, Maysinger D (2010) Microglial uptake and response to gold nanoparticles: the effects of nanomorphology and surface. ACS Nano 4:2595–2606
Iadecola C, Anrather J (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17:796–808
Keller AF, Gravel M, Kriz J (2009) Live imaging of amyotrophic lateral sclerosis pathogenesis: disease onset is characterized by marked induction of GFAP in Schwann cells. Glia 57:1130–1142
Keller F, Gravel M, Kriz J (2011) Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice. Exp Neurol 228:69–79
Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J et al (2004) Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med 10:719–726
Kriz J, Lalancette-Hébert M (2009) Inflammation, plasticity and real-time imaging after cerebral ischemia. Acta Neuropathol 117:497–509
Lagier-Tourenne C, Cleveland DW (2009) Rethinking ALS: the FUS about TDP-43. Cell 136:1001–1004
Lalancette-Hébert M, Phaneuf D, Soucy G, Weng YC, Kriz J (2009) Live imaging of Toll-like receptor 2 response in cerebral ischaemia reveals a role of olfactory bulb microglia as modulators of inflammation. Brain 132:940–954
Lalancette-Hébert M, Moquin A, Choi AO, Kriz J, Maysinger D (2010) Lipopolysaccharide-QD micelles induce marked induction of TLR2 and lipid droplet accumulation in olfactory bulb microglia. Mol Pharm 7(4):1183–1194
Laping NJ, Teter B, Nichols NR, Rozovsky I, Finch CE (1994) Glial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors. Brain Pathol 4:259–275
Lepore AC, Dejea C, Carmen J, Rauck B, Kerr DA, Sofroniew MV et al (2008) Selective ablation of proliferating astrocytes does not affect disease outcome in either acute or chronic models of motor neuron degeneration. Exp Neurol 211:423–432
Lo EH, Dalkara T, Moskowitz MA (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4:399–415
Luo J, Ho P, Steinman L, Wyss-Coray T (2008) Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease. J Neuroinflammation 5:6
Ma D, Jin S, Li E, Doi Y, Parajuli B, Noda M et al (2012) The neurotoxic effect of astrocytes activated with toll-like receptor ligands. J Neuroimmunol 254:10–18. doi:pii: S0165-5728(12)00254-8
Magnus T, Carmen J, Deleon J, Xue H, Pardo AC, Lepore AC et al (2008) Adult glial precursor proliferation in mutant SOD1G93A mice. Glia 56:200–208
Maragakis NJ, Rothstein JD (2006) Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2:679–689
Maysinger D, Behrendt M, Lalancette-Hebert M, Kriz J (2007) Real-time imaging of astrocyte response to quantum dots: in vivo screening model system for biocompatibility of nanoparticles. Nano Lett 7:291–302
McGeer PL, McGeer EG, Kawamata T, Yamada T, Akiyama H (1991) Reactions of the immune system in chronic degenerative neurological diseases. Can J Neurol Sci 18:376–379
Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H et al (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10:615–622
Nagele RG, Wegiel J, Venkataraman V, Imaki H, Wang KC, Wegiel J (2004) Contribution of glial cells to the development of amyloid plaques in Alzheimer’s disease. Neurobiol Aging 25:663–674
Nathan C, Ding A (2010) Nonresolving inflammation. Cell 140(6):871–882
Nawashiro H, Messing A, Azzam N, Brenner M (1998) Mice lacking gfap are hypersensitive to traumatic cerebrospinal injury. Neuroreport 9:1691–1696
Nguyen VT, Benveniste EN (2000) Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/macrophages. J Biol Chem 275: 23674–23684
Olabarria M, Noristani HN, Verkhratsky A, Rodríguez JJ (2010) Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer’s disease. Glia 58:831–838
Parpura V, Zorec R (2010) Gliotransmission: exocytotic release from astrocytes. Brain Res Rev 63:83–92
Parpura V, Heneka MT, Montana V, Oliet SH, Schousboe A, Haydon PG et al (2012) Glial cells in (patho)physiology. J Neurochem 121:4–27
Pekny M (2001) Astrocytic intermediate filaments: lessons from gfap and vimentin knock-out mice. Prog Brain Res 132:23–30
Pekny M, Nilsson M (2005) Astrocyte activation and reactive gliosis. Glia 50:427–434
Pekny M, Johansson CB, Eliasson C, Stakeberg J, Wallen A, Perlmann T, Lendahl U, Betsholtz C, Berthold CH, Frisen J (1999) Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J Cell Biol 145:503–514
Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A 91:10625–10629
Petzold A, Keir G, Kerr M, Kay A, Kitchen N, Smith M, Thompson EJ (2006) Early identification of secondary brain damage in subarachnoid hemorrhage: a role for glial fibrillary acidic protein. J Neurotrauma 23:1179–1184
Pihlaja R, Koistinaho J, Kauppinen R, Sandholm J, Tanila H, Koistinaho M (2011) Multiple cellular and molecular mechanisms are involved in human Aβ clearance by transplanted adult astrocytes. Glia 59:1643–1657
Quintana A, Müller M, Frausto RF, Ramos R, Getts DR, Sanz E et al (2009) Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis. J Immunol 183:2079–2088
Quintana A, Erta M, Ferrer B, Comes G, Giralt M, Hidalgo J (2012) Astrocyte-specific deficiency of interleukin-6 and its receptor reveal specific roles in survival, body weight and behavior. Brain Behav Immun 27(1):162–173. doi:pii: S0889-1591(12)00473-4
Ransom B, Behar T, Nedergaard M (2003) New roles for astrocytes (stars at last). Trends Neurosci 26:520–522
Ridet JL, Malhotra SK, Privat A, Gage FH (1997) Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20:570–577
Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. N Engl J Med 344:1688–1700
Silver J, Miller JH (2004) Regeneration beyond the glial scar. Nat Rev Neurosci 5:146–156
Stoll G, Jander S, Schroeter M (1998) Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 56:149–171
Stone DJ, Rozovsky I, Morgan TE, Anderson CP, Finch CE (1998) Increased synaptic sprouting in response to estrogen via an apolipoprotein e-dependent mechanism: implications for Alzheimer’s disease. J Neurosci 18:3180–3185
Swarup V, Phaneuf D, Dupré N, Petri S, Strong M, Kriz J et al (2011a) Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor-κB-mediated pathogenic pathways. J Exp Med 208:2429
Swarup V, Phaneuf D, Bareil C, Roberston J, Kriz J, Julien JP (2011b) Pathological hallmarks of ALS/FTLD in transgenic mice produced with genomic fragments encoding wild-type or mutant forms of human TDP-43. Brain 134:2610–2626
Tan L, Gordon KB, Mueller JP, Matis LA, Miller SD (1998) Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes. J Immunol 160:4271–4279
Trendelenburg G, Dirnagl U (2005) Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 50:307–320
Vissers JL, Mersch ME, Rosmalen CF, van Heumen MJ, van Geel WJ, Lamers KJ et al (2006) Rapid immunoassay for the determination of glial fibrillary acidic protein (gfap) in serum. Clin Chim Acta 366:336–340
Wilhelmsson U, Bushong EA, Price DL, Smarr BL, Phung V, Terada M et al (2006) Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc Natl Acad Sci U S A 103:17513–17518
Wyss-Coray T, Mucke L (2002) Inflammation in neurodegenerative disease–a double-edged sword. Neuron 35:419–432
Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH et al (2006) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11:251–253
Yuanshu D, Benveniste EN (2001) Immune function of astrocyte. Glia 36:180–190
Zhu L, Ramboz S, Hewitt D, Boring L, Grass DS, Purchio AF (2004) Non-invasive imaging of GFAP expression after neuronal damage in mice. Neurosci Lett 367:210–212
Acknowledgement
This work was supported by the Canadian Institutes of Health Research (CIHR) and Heart and Stroke Foundation of Quebec (HSFQ). J.K. is a Senior Scholar from the Fonds de la Recherche en Santé du Québec (FRSQ).
Conflict of interest statement The author declares no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kriz, J. (2013). Neuron–Astrocyte Interactions in Neuroinflammation. In: Suzumura, A., Ikenaka, K. (eds) Neuron-Glia Interaction in Neuroinflammation. Advances in Neurobiology, vol 7. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8313-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8313-7_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8312-0
Online ISBN: 978-1-4614-8313-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)